Founding Partner
Federal safety regulators have announced a major recall involving certain Boston Scientific Accolade pacemakers and related cardiac devices after reports connected the products to thousands of injuries and multiple deaths. The U.S. Food and Drug Administration classified the correction as a Class I recall, the agency’s highest-risk category reserved for situations involving a reasonable probability of serious injury or death.
According to federal regulators, a software defect may cause affected pacemakers to enter what is known as “Safety Mode.” While this backup mode is intended to provide temporary operation under limited circumstances, regulators warn it may not provide adequate long-term pacing support for patients who depend on these devices to regulate heart rhythms.
Pacemakers are implanted medical devices used by patients with serious cardiac conditions. These devices help maintain stable heart rhythms by delivering electrical impulses to the heart. When a pacemaker malfunctions or fails to provide adequate pacing therapy, the consequences may become life-threatening within seconds or minutes.
The recall follows reports involving approximately 2,557 serious injuries and four deaths connected to the affected devices. Patients who rely on continuous pacing support may face elevated risks if the device enters Safety Mode unexpectedly or experiences related software problems.
Consumers and families impacted by defective pacemakers may have legal rights. Individuals who suffered injuries, emergency medical events, additional surgeries, worsening heart conditions, or other complications may be eligible to pursue compensation through a product liability lawsuit.
Pacemakers are small electronic medical devices implanted in the chest to help regulate abnormal heart rhythms. They are commonly prescribed for patients suffering from conditions such as bradycardia, arrhythmias, heart block, and other disorders affecting the heart’s electrical system.
The device monitors the heart’s rhythm and delivers electrical signals when necessary to maintain a proper heartbeat. Many patients depend entirely or partially on these devices to survive and maintain stable cardiac function.
Modern pacemakers contain sophisticated software systems designed to monitor battery life, pacing performance, telemetry communication, and device operation. When software or electrical systems malfunction, patients may face severe consequences.
Pacemaker complications may include:
Patients implanted with pacemakers often believe these devices have undergone extensive testing and safety review. When defects emerge after widespread use, patients may face unexpected medical emergencies and emotional distress.
According to federal regulators, the recall involves software defects affecting certain Boston Scientific Accolade pacemakers and CRT-P cardiac devices. The issue reportedly involves the device entering “Safety Mode,” which limits pacing functionality.
Safety Mode is not intended to provide permanent or long-term pacing therapy. Regulators warn that patients who rely heavily on pacing support may experience inadequate cardiac therapy if the device remains in this backup operating condition.
The issue reportedly stems from software and telemetry problems associated with earlier firmware updates. Boston Scientific previously released the Brady SMR5 software update to reduce risks involving Safety Mode activation. However, regulators indicate the earlier update introduced additional problems involving telemetry shutdown and battery performance.
The company has now introduced the Brady SMR6 firmware update to address these concerns. The updated software reportedly aims to correct:
Although regulators are not recommending surgical removal of the devices at this time, patients are being advised to consult healthcare providers regarding necessary software updates and ongoing monitoring.
The recall announcement references approximately 2,557 reported injuries and four deaths associated with the affected devices. These reports have raised substantial concerns regarding patient safety and device reliability.
Individuals relying on pacemakers may experience severe symptoms if pacing support becomes inadequate. Symptoms associated with device malfunction may include:
For some patients, a malfunctioning pacemaker may trigger life-threatening cardiac events requiring emergency intervention.
In many situations, patients may not immediately realize their symptoms are related to device failure. Some individuals may experience intermittent symptoms that worsen over time before the issue is identified.
Patients may also face emotional distress and anxiety after learning that an implanted device responsible for maintaining cardiac function may not operate properly.
The primary concern identified by regulators involves the device entering Safety Mode unexpectedly. Safety Mode is intended as a backup operational state used during certain malfunctions. However, the mode may significantly reduce pacing capabilities.
Patients who are pacing-dependent face the greatest risks. If the device cannot provide adequate pacing support, the heart may not maintain proper rhythm and circulation.
Potential consequences include:
The seriousness of these risks explains why federal regulators categorized the recall as Class I. This classification is reserved for defects capable of causing serious injury or death.
Patients with underlying cardiac disease may face particularly elevated risks if pacing support becomes unreliable.
Boston Scientific has announced a software correction involving installation of the Brady SMR6 firmware update. According to the company, the update may be performed during a routine office visit using specialized programming equipment.
Importantly, regulators currently are not recommending removal of affected devices. Instead, physicians are being urged to prioritize updates for patients who are most dependent on pacing therapy.
While the software update may reduce certain risks, some patients may remain concerned about long-term reliability and device performance.
Patients may still require:
Even when surgery is avoided, patients may experience significant stress and medical disruption.
Patients injured by defective pacemakers may have legal rights under product liability laws. Manufacturers of implanted medical devices have a responsibility to design, manufacture, test, and monitor products for safety.
Potential legal claims may include:
Individuals harmed by recalled pacemakers may seek compensation for:
Pacemaker litigation often involves allegations that manufacturers knew or should have known about safety risks associated with the device or related software systems.
The recall follows multiple lawsuits involving alleged pacemaker defects from various manufacturers. Recent litigation has included allegations involving device malfunctions, improper rhythm detection, electrical abnormalities, and emergency replacement surgeries.
These lawsuits suggest growing concerns regarding the reliability of certain implanted cardiac devices and associated software systems.
Implanted devices present unique risks because patients depend on them continuously. When defects occur, patients may face emergency situations requiring immediate medical care.
Consumers harmed by defective cardiac devices may face long recovery periods, additional surgeries, and ongoing monitoring.
Possibly. Patients who suffered injuries, complications, emergency medical events, or additional procedures related to a recalled pacemaker may have legal claims.
Symptoms may include dizziness, fainting, fatigue, chest pain, irregular heartbeat, shortness of breath, or worsening heart failure symptoms. Patients experiencing symptoms should seek medical attention immediately.
Not necessarily. Some patients may qualify for compensation based on injuries, medical monitoring, emotional distress, or complications caused by the defective device or software malfunction.
Compensation may include medical costs, future treatment expenses, lost wages, pain and suffering, emotional distress, and other damages.
Families who lost loved ones due to defective medical devices may have the right to pursue wrongful death claims depending on state law and the circumstances involved.
No. The recall involves certain Accolade pacemakers and CRT-P devices. Patients should consult their healthcare providers to determine whether their device is affected.
Healthcare providers may identify Safety Mode activation during device monitoring or evaluation. Patients should report symptoms and discuss device performance concerns with their cardiologists.
Deadlines vary depending on state law and individual circumstances. Acting promptly may help preserve important legal rights and evidence.
Patients who suffered complications involving Boston Scientific Accolade pacemakers may have legal options. If you or a loved one experienced injuries, emergency cardiac events, additional medical procedures, or other complications connected to a recalled pacemaker, Parker Waichman LLP is investigating claims nationwide.
Parker Waichman LLP offers free consultations for individuals affected by defective pacemakers and other recalled medical devices.
Call Parker Waichman LLP today at 1-800-YOUR-LAWYER (1-800-968-7529) to discuss your potential claim and learn about your legal rights. Regardless of your location or where your injury occurred, our nationwide product injury law firmis ready to assist you.
Parker Waichman LLP
Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
We handle mass torts cases nationwide. Please contact our office to learn more.